Progyny: Growth Has Returned (Rating Upgrade)

2025-11-19 08:45:00 ET

Progyny ( PGNY ) is the leading go-to provider of fertility benefits to company employees in the US. The firm has enjoyed a series of positive news releases of late, sending the stock price up from $18.01 at the close of Nov 6 to above $27 on Nov 17—a gain of over 50% in just 8 trading days. After a slight pullback, shares are now around $26. Investors will want to know not only what likely caused this share-price jump and whether their upward momentum is sustainable, but also what to make of the risk-reward profile of the company and its stock at present. But perhaps before I answer these questions, I’ll provide some context in relation to my previous coverage of Progyny, which I should add is a stock I have had in my own portfolio for a few years....

Read the full article on Seeking Alpha

For further details see: